F-0506 | MWYRPDLDERKQQKRD | C94H148N30O28S | 2178.48 | 154938-34-8 | H-Met-Trp-Tyr-Arg-Pro-Asp-Leu-Asp-Glu-Arg-Lys-Gln-Gln-Lys-Arg-Glu-OH |
F-0507 | Nuclear Factor NF-KB Inhibitor SN50 | C129H230N36O29S | 2781.54 | 213546-53-3 | H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH |
F-0601 | Ac-DRGDS | C21H34N8O12 | 590.55 | 151997-55-6 | Ac-Asp-Arg-Gly-Asp-Ser-OH |
F-0602 | Ac-DRLDS | C25H42N8O12 | 646.66 | | Ac-Asp-Arg-Leu-Asp-Ser-OH |
F-0603 | Fibrinogen Receptor Antagonist | C22H36N8O9S2 | 620.71 | | Ac-Pen-Arg-Gly-Asp-Cys-OH (Disulfide bond) |
F-0604 | RRGDME | C28H50N12O11S | 762.85 | 328946-37-8 | H-Arg-Arg-Gly-Asp-Met-Glu-OH |
F-0605 | RGD | C12H22N6O6 | 346.34 | 99896-85-2 | H-Arg-Gly-Asp-OH |
F-0605-2 | RGDC | C15H27N7O7S | 449.49 | 109292-46-8 | H-Arg-Gly-Asp-Cys-OH |
F-0605-3 | RGDS | C15H27N7O8 | 433.42 | 91037-65-9 | H-Arg-Gly-Asp-Ser-OH |
F-0605-4 | RGDSPASSKP | C40H68N14O16 | 1001.07 | 91575-25-6 | H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH |
F-0606 | D-RGDW | C23H32N8O7 | 532.56 | 144161-76-2 | H-D-Arg-Gly-Asp-Trp-OH |
F-0605-5 | RGDV | C17H31N7O7 | 445.48 | 93674-99-8 | H-Arg-Gly-Asp-Val-OH |
F-0607 | RGES | C16H29N7O8 | 447.45 | 93674-97-6 | H-Arg-Gly-Glu-Ser-OH |
F-0608 | RGE | C13H24N6O6 | 360.37 | 20274-91-3 | H-Arg-Gly-Glu-OH |
F-0609 | DRGDS | C19H32N8O11 | 548.51 | 151997-53-4 | H-Asp-Arg-Gly-Asp-Ser-OH |
F-0610 | DRLDS | C23H40N8O11 | 604.61 | 145880-23-5 | H-Asp-Arg-Leu-Asp-Ser-OH |
F-0611 | Bifunctional Antiplatelet Agent | C53H103N25O13 | 1298.56 | | H-Lys-Arg-Lys-Arg-Lys-Arg-Arg-Gly-Asp-Val-OH |
F-0612 | XJ735 | C23H32N8O7 | 532.56 | 153381-95-4 | Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) |
F-0613 | c(RADfC) | C25H36N8O7S | 592.68 | 1055991-02-0 | Cyclo(-Arg-Ala-Asp-D-Phe-Cys) |
F-0614 | c(RADfV) | C27H40N8O7 | 588.66 | 137813-36-6 | Cyclo(-Arg-Ala-Asp-D-Phe-Val) |